A AstraZeneca
Swedish-British pharmaceutical company
Updates & Highlights
Stocktwits · about 14 hours ago
AstraZeneca's Rare Disease Setback Is A 'Clear Positive' For Omeros, Says This Analyst – A Look At Some Key Highlights
Seeking Alpha · 1 day ago
AstraZeneca and Daiichi win EU label expansion for Datroway in breast cancer
TipRanks · 2 days ago
AstraZeneca Wins EU Nod for Datroway, Strengthening TNBC Oncology Portfolio
Recent Openings
View all 10 jobs arrow_forwardAll Jobs
Associate Principal AI Research Scientist (Fundamental AI Research for Digital Biology)
location_on Boston, MA, US
Associate Principal AI& ML Engineer – Evinova
location_on London, ENG, GB
Associate Principal AI Research Scientist (Fundamental AI Research for Digital Biology)
location_on Wilmington, DE, US
Culture & Mission
Benefits & Perks
Competitive Salary
Market-rate compensation
Equity/Stock Options
Ownership in the company
Health Insurance
Medical, dental & vision
Remote Work
Work from anywhere flexibility
Learning Budget
Professional development
Generous PTO
Paid time off
401(k) Match
Retirement savings
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at AstraZeneca?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company arrow_forwardNews & Press
20 recentAstraZeneca's Rare Disease Setback Is A 'Clear Positive' For Omeros, Says This Analyst – A Look At Some Key Highlights
AstraZeneca's Rare Disease Setback Is A 'Clear Positive' For Omeros, Says This Analyst – A Look At Some Key Highlights
Stocktwits · about 14 hours ago
AstraZeneca and Daiichi win EU label expansion for Datroway in breast cancer
AstraZeneca and Daiichi win EU label expansion for Datroway in breast cancer
Seeking Alpha · 1 day ago
AstraZeneca Wins EU Nod for Datroway, Strengthening TNBC Oncology Portfolio
AstraZeneca Wins EU Nod for Datroway, Strengthening TNBC Oncology Portfolio
TipRanks · 2 days ago
Friday Five – Alnylam's quarter-cutting quarter, AstraZeneca's Claudin consolation, Capricor's statistical shock sequel…and more
Friday Five – Alnylam's quarter-cutting quarter, AstraZeneca's Claudin consolation, Capricor's statistical shock sequel…and more
FirstWord Pharma · 2 days ago
Fund Update: 42,335 ASTRAZENECA (AZN) shares added to STEPHENS INC |AR| portfolio
Fund Update: 42,335 ASTRAZENECA (AZN) shares added to STEPHENS INC |AR| portfolio
Quiver Quantitative · 3 days ago
Earnings roundup: Biogen’s ‘resiliency,’ AstraZeneca’s growth pitch and GSK’s oncology push
Earnings roundup: Biogen’s ‘resiliency,’ AstraZeneca’s growth pitch and GSK’s oncology push
BioPharma Dive · 4 days ago
Mohit Manrao: AstraZeneca Reports Positive Phase III Results in Gastric Cancer
Mohit Manrao: AstraZeneca Reports Positive Phase III Results in Gastric Cancer
Oncodaily · 4 days ago
AstraZeneca (LSE:AZN) Stock In Focus After Sone Ve Win And Mixed Ultomiris Data
AstraZeneca (LSE:AZN) Stock In Focus After Sone Ve Win And Mixed Ultomiris Data
Yahoo Finance · 4 days ago
AstraZeneca (LSE:AZN) Stock In Focus After Sone Ve Win And Mixed Ultomiris Data
AstraZeneca (LSE:AZN) Stock In Focus After Sone Ve Win And Mixed Ultomiris Data
Yahoo! Finance Canada · 4 days ago
This Week's Healthcare Earnings: Tenet, CHS, AstraZeneca
This Week's Healthcare Earnings: Tenet, CHS, AstraZeneca
Law360 · 4 days ago
AstraZeneca up 6% in Q2 as oncology drives growth
AstraZeneca up 6% in Q2 as oncology drives growth
EMJ · 5 days ago
AstraZeneca Loses Court Bid To Block Maine Contract Pharmacy Law
AstraZeneca Loses Court Bid To Block Maine Contract Pharmacy Law
Bloomberg Law News · 5 days ago
AstraZeneca reports Phase III results for Ultomiris and Sone-Ve
AstraZeneca reports Phase III results for Ultomiris and Sone-Ve
Clinical Trials Arena · 5 days ago
AstraZeneca Stock: What We Thought of Earnings
AstraZeneca Stock: What We Thought of Earnings
Morningstar · 5 days ago
AstraZeneca Stock: What We Thought of Earnings
AstraZeneca Stock: What We Thought of Earnings
Morningstar · 5 days ago
AstraZeneca results: H1 and Q2 2026
AstraZeneca results: H1 and Q2 2026
BioSpace · 5 days ago
AstraZeneca's Claudin 18.2-targeting ADC passes pivotal gastric cancer test
AstraZeneca's Claudin 18.2-targeting ADC passes pivotal gastric cancer test
FirstWord Pharma · 5 days ago
AstraZeneca PLC (AZN) Q2 2026 Earnings Call Highlights: Strong Oncology and Rare Disease Growth ...
AstraZeneca PLC (AZN) Q2 2026 Earnings Call Highlights: Strong Oncology and Rare Disease Growth ...
Yahoo Finance · 5 days ago
Recon: WHO releases first interim list of medical device authorities; AstraZeneca using AI to hedge late-stage risks
Recon: WHO releases first interim list of medical device authorities; AstraZeneca using AI to hedge late-stage risks
RAPS · 5 days ago
AstraZeneca boss denies AI will hit jobs
AstraZeneca boss denies AI will hit jobs
The Times · 5 days ago